Modulation Therapeutics, Inc.
CAGE Code: 6G0X1
NCAGE Code: 6G0X1
Status: Active
Type: Manufacturer
Dun & Bradstreet (DUNS): 968675244
Summary
Modulation Therapeutics, Inc. is an Active Manufacturer with the Cage Code 6G0X1 and is tracked by Dun & Bradstreet under DUNS Number 968675244..
Address
64 Medical Center Dr
Morgantown WV 26505-3409
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
Nancy Marie Enterprises Wagner Robert Corp Motown Taxi, Llc Calvin R. Mcdaniel, Ii , Inc. Cws Co Land Design Studio The Cgs Contracting Llc Haley Coombs North Star Electric University Tire Center Inc Bioimaginix Llc Hari Hotels, Llc Augusta Computer Services, Llc Horizon Research Consultants Inc Petroplus And Associates Inc Job Accommodation Network Impact Therapy Associates Mountaineer Psychological Services, Melissa White Roberts Supply Inc
Frequently Asked Questions (FAQ) for CAGE 6G0X1
- What is CAGE Code 6G0X1?
- 6G0X1 is the unique identifier used by NATO Organizations to reference the physical entity known as Modulation Therapeutics, Inc. located at 64 Medical Center Dr, Morgantown WV 26505-3409, United States.
- Who is CAGE Code 6G0X1?
- 6G0X1 refers to Modulation Therapeutics, Inc. located at 64 Medical Center Dr, Morgantown WV 26505-3409, United States.
- Where is CAGE Code 6G0X1 Located?
- CAGE Code 6G0X1 is located in Morgantown, WV, USA.
Contracting History for CAGE 6G0X1 Most Recent 25 Records
- HHSN261201700035C
- "Targeted Ac-225-Radiopharmaceutical For Metastatic Uveal Melanoma" Period Of Performance: 9/18/2017 - 9/17/2022
- 13 Sep 2021
- "Targeted Ac-225-Radiopharmaceutical For Metastatic Uveal Melanoma" Period Of Performance: 9/18/2017 - 9/17/2022
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,999,987.00
- Department Of Health And Human Services (Hhs)
- HHSN261201700035C
- "Targeted Ac-225-Radiopharmaceutical For Metastatic Uveal Melanoma"Period Of Performance: 9/18/2017 - 9/17/2020
- 13 Sep 2019
- "Targeted Ac-225-Radiopharmaceutical For Metastatic Uveal Melanoma"Period Of Performance: 9/18/2017 - 9/17/2020
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,999,987.00
- Department Of Health And Human Services (Hhs)
- HHSN261201700035C
- "Targeted Ac-225-Radiopharmaceutical For Metastatic Uveal Melanoma" Period Of Performance: 9/18/2017 - 9/17/2021
- 15 Sep 2020
- "Targeted Ac-225-Radiopharmaceutical For Metastatic Uveal Melanoma" Period Of Performance: 9/18/2017 - 9/17/2021
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,999,987.00
- Department Of Health And Human Services (Hhs)